Skip to main content
. Author manuscript; available in PMC: 2013 Jul 1.
Published in final edited form as: J Neuropathol Exp Neurol. 2012 Jul;71(7):654–664. doi: 10.1097/NEN.0b013e31825d06b7

Table.

Case Data

Case Braak and Braak Stage CERAD plaque density/presence of senile plaques in hippocampus* Cognitive status Age (y) Sex PMI (h) RIN
BM1 0 None/0 No neurological history and no evidence of dementia 70 M 24 6.2
BM2 0 None/0 No neurological history and no evidence of dementia 73 F 25 4.5
BM3 0 None/0 No neurological history and no evidence of dementia 75 F 36 5.4
BM4 0 None/0 No neurological history and no evidence of dementia 77 F 46 4.5
BVAX1 I Sparse/1+ (D) CDR 0 77 F 6 4.8
BVAX2 I None/0 CDR 0 91 F 16 6.1
BVAX3 I Sparse/1+ (N) CDR 0 94 M 1.5 6.7
BVAX4 II Sparse/1+ (D) CDR 0 90 M 15 5.7
BVAX5 II None/0 CDR 0.5 96 F NA 5.8
BVAX6 IV Frequent, temporal only/ 2+ (N) CDR 1 92 M NA 5.7
BVAX7 IV Moderate/ 2+ (N) CDR 1 96 F 3.5 7.4
MADRC1 IV Sparse/ 1+ (D & N) Mild dementia 103 F 5 6.0
*

0 = none; 1+ = mild; 2+ = moderate, 3+ = severe, 4+ = very severe.

BM1 – 4= Boston Medical Center cases 1–4; BVAX1-6 = Brain Bank of the Boston University Alzheimer Disease Center cases 1–6; CERAD = The Consortium to Establish a Registry for Alzheimer's Disease; CDR 0–1 = clinical dementia rating scores 0 – 1; D = diffuse plaques; F = female; M = male; MADRC1= Massachusetts Alzheimer Disease Research Center case 1; N = neuritic plaques; PMI = postmortem interval; RIN= RNA integrity number.